Application Number Funding Recommendation Title Score DT1-00652 Recommended A CIRM Disease Team for the Treatment and Cure of Diabetes 94 DT1-00672 Recommended Development of a Cell Replacement Therapy Product for Insulin Dependent Diabetes 92 DT1-00710 Recommended {REDACTED} Cardiovascular Regenerative Team 92 DT1-00674 Recommended Stem Cell Therapy for Muscular Dystrophy 90 DT1-00698 Recommended {REDACTED} Heart Disease Regenerative Medicine Team Planning Award 90 DT1-00671 Recommended Pluripotent Stem Cell–Based Therapy for Heart Disease 89 DT1-00657 Recommended Stem cell based treatment strategy for Age-related Macular Degeneration (AMD) 86 DT1-00683 Recommended Stem Cell Therapy for AIDS- Disease Team Planning 85 DT1-00704 Recommended "Stem Cell Therapies for Heart Failure" 80 DT1-00701 Recommended STEM CELL GENE THERAPY FOR SICKLE CELL DISEASE 80 DT1-00653 Recommended Clinical Regenerative Wound Healing With Stem Cells 80 DT1-00700 Recommended Huntington's Disease Team 80 DT1-00688 Recommended Develop a cell replacement therapy for Parkinson's disease using human embryonic stem cells 80 DT1-00709 Recommended CIRM Planning Grant in Leukemia 79 DT1-00697 Recommended CIRM Disease Team Planning Award 79 DT1-00708 Recommended Genetically-modified neural stem cells for treatment of high-grade glioma 78 DT1-00659 Recommended Motor neuron diseases: Finding cures through basic, translational, and clinical collaboration 77 DT1-00669 Recommended Development of a Stem Cell Therapy to Promote Functional Recovery in Stroke 77 DT1-00690 Recommended Stem cells for neuroprotection of photoreceptors in retinitis pigmentosa 77 DT1-00696 Recommended Stem Cell-Mediated Oncocidal Therapy of Primary & Metastatic Brain Tumors 76 DT1-00656 Recommended A CIRM Disease Team for the Repair of Traumatically Injured and Arthritic Cartilage 75 DT1-00658 Not recommended Allogeneic Mesenchymal Stem Cells for the Treatment of Acute Lung Injury 74 DT1-00675 Recommended Human Stem Cell Approaches to Alzheimers Disease Therapies 73 DT1-00693 Not recommended Melanoma Stem Cell 72 DT1-00702 Not recommended Stem Cells for Vascular Tissue Regeneration 71 DT1-00650 Not recommended Human Embryonic Stem Cells for Heart Failure 70 DT1-00668 Not recommended Regenerative Strategies for Cardiac and Vascular Injury 70 DT1-00715 Not recommended Stem Cell Mediated Therapy of Genetic Degenerative Childhood Disorders-Particularly Neurodegenerative Lysosomal Storage Diseases 69 DT1-00712 Not recommended Stem Cell Therapies for Brain Tumors 68 DT1-00670 Not recommended Stem Cell Therapy for the Lysosomal Storage Diseases, the Major Cause of Neurodegeneration in Children 66 DT1-00707 Not recommended Neonatal Brain Ischemia: Neuroimaging as a Basis for Rational Stem Cell Therapy 62 DT1-00681 Not recommended Development of novel therapeutics for stem-like cancer cells 60 DT1-00694 Not recommended Development of A Cell-based Therapy for Cerebral Palsy 0 DT1-00673 Not recommended Ex Vivo Small Molecule Induced Hematopoietic Stem Cell Expansion For Transplantation 0 DT1-00665 Not recommended Stem cell-based strategies for treatment of Alzheimer's and other neurodegenerative disease 0 DT1-00651 Not recommended Planning optimal strategies for applications of stem and progenitor cell therapies in spinal cord injury 0 DT1-00677 Not recommended Mesenchymal stem cells for therapy of pulmonary fibrosis 0 DT1-00692 Not recommended Transendocardial Autologous Serum Autologous Mesenchymal Stem Cell delivery using Transendocardial Delivery For Heart Failure Trial 0 DT1-00703 Not recommended Stroke (Cerebral Ischemia) Disease Team of {REDACTED} 0 DT1-00660 Not recommended Early Breast Cancer Predictive Diagnostics: The Cancer Initiating Cell and Personalized Prevention in Breast Cancer 0 DT1-00699 Not recommended Feasibility and benefit-risk ratio of high cell dose allogeneic umbilical cord blood stem cell transplantation as a curative stem cell therapy for severe forms of autoimmune diseases 0 DT1-00679 Not recommended {REDACTED} California Team Planning for Rapid Translation of Mesenchymal Stem Cell (MSC)-based Research to Advance Islet Transplantation for Treatment of Type 1 Diabetes 0 DT1-00705 Not recommended {REDACTED} Liver Cell Therapies Team 0 DT1-00691 Not recommended Development of Novel Therapeutic Strategies for Pulmonary Vascular Disease Using Stem Cells Derived From Patients' Diseased Arterial Tissues 0 DT1-00678 Not recommended Remyelination for the Treatment of Spinal Cord Injury 0 DT1-00682 Not recommended Liver Disease Team for development of novel tools and antiviral therapies from human embryonic and pluripotent stem cells 0 DT1-00687 Not recommended Musculoskeletal Tissue Regeneration 0 DT1-00714 Not recommended Optimization of Stem Cell Transplantation to Treat Acute Myocardial Infarction 0 DT1-00664 Not recommended Stem-Cell-Based Regenerative Therapies for Arthritis 0 DT1-00689 Not recommended Treatment of Cardiac Arrhythmias by Stem Cell Therapies. 0 DT1-00663 Not recommended STEM CELL-BASED TREATMENT OF OROFACIAL TUMORS 0 DT1-00685 Not recommended Planning for a Type I and Type II Diabetes Disease Team 0 DT1-00676 Not recommended Treatment of Type II Diabetes Mellitus: Mitochondrial Resuscitation + Beta Cell Supplementation 0 DT1-00695 Not recommended A translational research project for defining a stem cell formulation for treating ischemic stroke based on comparison of adult neural stem cells and neural stem cells derived from embryonic stem cells. 0 DT1-00711 Not recommended Amniotic Fluid Stem Cell Therapy for Acute Lung Injury 0 DT1-00680 Not recommended To develop Stem cell derived corneal tissue as a substitute for donor-sourced cornea normally used for transplantation of partial thickness grafts 0 DT1-00666 Not recommended Development of Cancer Stem Cell Niche Therapeutics 0 DT1-00667 Not recommended Cancer Stem Cell Therapeutic Targets Derived from Human Embryonic Stem Cells 0 DT1-00684 Not recommended Stem cell therapeutic capable of targeting pediatric brain tumors 0